Search results
Michael Rosenblatt, M.D., is a Senior Advisor at Flagship Pioneering and serves as an independent director on a number of Flagship company boards and provides guidance to Flagship and Flagship companies.
Jul 13, 2016 · Dr. Rosenblatt was named Senior Vice President for Research at Merck, Sharpe & Dohme Research Laboratories in 1984, and spent nearly a decade at Merck, co-leading the worldwide development team for alendronate (FOSAMAX), Merck's bisphosphonate for osteoporosis and bone disorders.
Michael Rosenblatt, M.D., has held major leadership roles in academia and the biopharmaceutical industry, and currently serves as Senior Partner of Flagship Pioneering in Cambridge, MA. Dr. Rosenblatt was Chief Medical Officer (CMO) for Merck from 2009-2016.
DR. MICHAEL ROSENBLATT. Senior Partner, Flagship Pioneering. Harvard Medical School Board of Fellows. Dr. Rosenblatt’s career has been in academia, the pharmaceutical industry and biotech/venture. He is a physician, scientist, educator and leader in healthcare.
Michael Rosenblatt is a Senior Partner of Flagship Pioneering, a venture capital firm that aims to build life sciences companies focused on human health and sustainability.
Michael Rosenblatt is Ebert Professor of Molecular Medicine, Harvard Medical School, and former Co-Director of the Harvard-MIT Division of Health Sciences and Technology.
Mar 11, 2024 · Since 2016, Rosenblatt has been at Flagship Pioneering—first as its CMO and now as senior advisor. In addition to advising many companies in the Flagship ecosystem, he played a pivotal role in helping Moderna navigate clinical development of its mRNA-based vaccine during the COVID-19 pandemic (Q#9).
Sep 29, 2016 · Michael Rosenblatt, newly appointed Chief Medical Officer of Flagship Ventures and former Chief Medical Officer at Merck & Co., discusses his move from industry to venture capital.
Chief Medical Officer Flagship Ventures. Biography. Dr. Rosenblatt’s career has been in academia, the pharmaceutical industry and biotech/venture. He is a physician, scientist, educator and leader in healthcare. He currently serves as an advisor to the biopharmaceutical industry and academia.
Scientist, academic, hospital and global healthcare company executive, Michael Rosenblatt, M.D., is executive vice president and chief medical officer at Merck. He is the company’s primary external advocate on medical issues and the independent voice of the patient inside Merck.
